LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

Search

Zai Lab Ltd ADR

Chiusa

SettoreSettore sanitario

17.53 1.74

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

16.7

Massimo

17.61

Metriche Chiave

By Trading Economics

Entrata

-607K

-51M

Vendite

-28M

100M

EPS

-0.46

Margine di Profitto

-51.215

Dipendenti

1,784

EBITDA

4.1M

-44M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+87.72% upside

Dividendi

By Acuity

Utili prossimi

6 ago 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-516M

1.9B

Apertura precedente

15.79

Chiusura precedente

17.53

Notizie sul Sentiment di mercato

By Acuity

16%

84%

29 / 344 Classifica in Healthcare

Zai Lab Ltd ADR Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

11 giu 2026, 23:56 UTC

News

Monster Beverage shares higher in after-market trading following Bernstein's initiation of coverage with a Market Perform rating. The stock has gained over four consecutive sessions.

11 giu 2026, 23:52 UTC

Macro Event
News
Correlated Moves

The Australian Dollar has gained against the Singapore Dollar, supported by a slight decline in consumer inflation expectations and recent geopolitical developments.

11 giu 2026, 23:51 UTC

News

The iShares Core U.S. Aggregate Bond ETF is trading lower in after-market hours, reflecting concerns over inflation following a rise in the producer price index.

11 giu 2026, 23:51 UTC

Correlated Moves
ETF Constituents
News
Social Media

SPDR S&P 500 ETF Trust rises in after-hours trading amid improved market sentiment and reduced geopolitical tensions in Iran, supported by strong performances from top holdings.

11 giu 2026, 23:51 UTC

Correlated Moves
ETF Constituents
News
Social Media

Invesco QQQ Trust Series I rises after hours, supported by a Nasdaq 100 rally driven by technology stocks and easing inflation concerns.

11 giu 2026, 23:51 UTC

News

The United States Oil Fund LP is higher in after-market trading amid reports of explosions in Iran raising concerns over oil supply stability.

11 giu 2026, 23:41 UTC

Social Media
News
Event

Adobe Inc. shares fell in after-market trading despite record revenue of $6.62 billion, as investor concerns grew over CFO Dan Durn's upcoming departure.

11 giu 2026, 23:41 UTC

ETF Constituents
Correlated Moves
Macro News
News

Vanguard Information Technology ETF rises after President Trump's decision to call off attacks against Iran, boosting investor confidence and contributing to gains in major indices.

11 giu 2026, 23:41 UTC

Social Media
News

Western Digital Corp initiated exchange agreements with investors for over 1 million shares of SanDisk, contributing to the stock's higher after-market hours movement.

11 giu 2026, 23:36 UTC

News
Correlated Moves

Ethereum is trading higher as market optimism rises amid U.S.-Iran tensions and the European Central Bank's interest rate hike. Earlier, it pulled back from a peak.

11 giu 2026, 23:31 UTC

News

NVIDIA shares are higher in after-market trading following an upgrade to 'AA' by S&P Global and the announcement of its 2026 Annual Meeting.

11 giu 2026, 23:26 UTC

ETF Constituents
Correlated Moves
News

Vanguard Growth ETF rises in after-market trading, buoyed by gains from Microsoft, NVIDIA, and Alphabet, despite remaining below its 20-day moving average.

11 giu 2026, 23:16 UTC

ETF Constituents
Social Media
News
Correlated Moves

The iShares Russell 2000 ETF rose in after-market hours, supported by the Russell 2000 index's significant gain and contributions from PR and SATS.

11 giu 2026, 23:11 UTC

News
Correlated Moves

CME Group plans to expand 24/7 gold trading, pending regulatory review. SPDR Gold Shares are rising in after-market hours amid geopolitical tensions.

11 giu 2026, 23:11 UTC

News

USD/PLN trades lower as natural gas storage exceeds forecasts and initial jobless claims rise unexpectedly. Volatility persists during Thursday's session.

11 giu 2026, 23:11 UTC

News
Correlated Moves

The USD/CZK is trading lower, reflecting a decline since Wednesday's close amid rising initial jobless claims and producer prices exceeding forecasts.

11 giu 2026, 23:06 UTC

Correlated Moves
News

Vanguard Total Bond Market ETF trades higher in after-market hours as producer prices exceed expectations, prompting bargain hunting despite potential interest rate hike concerns.

11 giu 2026, 23:06 UTC

News

Amgen engages Duke Clinical Research Institute to reassess Tavneos data amid FDA concerns, with shares trading higher in after-market hours.

11 giu 2026, 23:03 UTC

Social Media
Correlated Moves
News

iShares Silver Trust trades higher after geopolitical tensions in Iran raise interest in safe-haven assets, supported by gold's recent gains.

11 giu 2026, 23:03 UTC

ETF Constituents
News

The Vanguard Small-Cap ETF is higher in after-market trading, reflecting a broader upward trend in the Russell 2000 Index amid ongoing inflationary concerns.

11 giu 2026, 23:02 UTC

News

The USD/THB is lower as U.S. economic data raises inflation concerns, impacting sentiment and Federal Reserve policy expectations during Thursday's trading session.

11 giu 2026, 23:02 UTC

News

Gilead Sciences reported positive results from two Phase 3 trials for an HIV treatment. Shares are higher in after-market hours following a session pullback.

11 giu 2026, 23:02 UTC

News

The USD/HUF is trading lower, reflecting a drop since Wednesday. Rising jobless claims and surging producer prices raise concerns about labor market strength and inflation.

11 giu 2026, 23:02 UTC

Correlated Moves
News

The USD/SEK is declining, breaking a trend of higher daily closes, amid rising initial jobless claims that may impact Federal Reserve policy.

11 giu 2026, 22:51 UTC

Correlated Moves
News

USD/SGD declines amid natural gas storage data surpassing forecasts. The pair has experienced unusual volatility, peaking briefly before steady declines into the afternoon.

11 giu 2026, 22:51 UTC

Correlated Moves
News

The CHF/HKD is higher during Thursday's session, supported by the European Central Bank's recent interest rate hike amid inflation pressures.

11 giu 2026, 20:07 UTC

News
Correlated Moves

The European Central Bank raised interest rates by 25 basis points, supporting modest gains in GBP/HKD amid inflation pressures from the Middle East conflict.

11 giu 2026, 20:07 UTC

News
Correlated Moves

Natural gas storage data showed 108 billion cubic feet, surpassing forecasts. USD/NOK is trading higher, remaining above its 20-day moving average.

11 giu 2026, 20:07 UTC

News
Correlated Moves

The USD/DKK is lower in Thursday's session, reflecting a decline in the US Dollar Index amid rising initial jobless claims data.

11 giu 2026, 20:06 UTC

News
Correlated Moves

Intel Corp's stock is rising following a double upgrade from Bank of America, which raised its price target to $135 from $96.

Confronto tra pari

Modifica del prezzo

Zai Lab Ltd ADR Previsione

Obiettivo di Prezzo

By TipRanks

87.72% in crescita

Previsioni per 12 mesi

Media 32.4 USD  87.72%

Alto 44 USD

Basso 21.6 USD

Basato su 4 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Zai Lab Ltd ADR - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

4 ratings

3

Acquista

1

Mantieni

0

Vendi

Sentiment

By Acuity

29 / 344 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Zai Lab Ltd ADR

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses electric fields tuned to specific frequencies to kill tumor cells; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; Qinlock to treat gastrointestinal stromal tumors, and VYVGART, a human IgG1 antibody fragment for myesthenia gravis. The company also develops Tumor Treating Fields, a portable device for delivery of electric fields; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, and pancreatic cancer; and Bemarituzumab to treat gastric and gastroesophageal junction cancer patients. In addition, it develops Sulbactam/durlobactam, a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor for the treatment of serious infections caused by Acinetobacter; KarXT for the treatment of psychiatric and neurological conditions. It has license and collaboration agreement with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure to develop and commercialize Tumor Treating Fields; Deciphera to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx, to develop and commercialize efgartigimod; BMS to develop and commercialize tisotumab vedotin and repotrectinib; Mirati to research, develop, manufacture, and commercialize adagrasib; Amgen to develop and commercialize bemarituzumab; and Innoviva to develop and commercialize Sulbactam-Durlobactam; Karuna to develop and commercialize KarXT; and strategic collaboration with Pfizer for XACDURO. The company was incorporated in 2013 and is headquartered in Shanghai, China.
help-icon Live chat